EGFR and neoplasm: Baseline demographic characteristics, including sex, age, history of smoking, tumor–node–metastasis stage, ECOG-PS score, histological type, and epidermal growth factor receptor at the baseline, showed no significant difference between the responder and nonresponder groups.